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S U M M A R Y
While pulmonary Mycobacterium tuberculosis infections are recognized for their public health
implications, less is known about the infectiousness of extrapulmonary tuberculosis, speciﬁcally,
spinal tuberculosis or Pott’s disease. We present a case of spinal tuberculosis with concomitant active
pulmonary tuberculosis in the absence of chest radiographic abnormalities or symptoms, and review the
literature regarding infectiousness of concomitant spinal and pulmonary tuberculosis.
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Mycobacterium tuberculosis (MTB) has infected an estimated 2
billion persons worldwide and remains a leading cause of global
mortality.1 In 2007, over 13 000 tuberculosis (TB) cases were
reported in the USA.1 Nearly 20% of patients with TB develop
extrapulmonary manifestations. Skeletal TB accounts for 10–20%
of all extrapulmonary TB, with spinal involvement in 50–60% of all
skeletal TB cases or in <1% to 5% of all TB cases.2–9 Pott’s disease,
ﬁrst described by Percival Pott, is MTB infection of the vertebral
spine and typically involves thoracic and lumbar anterior vertebral
bodies. Complications can include vertebral collapse, paraplegia
and paraspinal abscesses.3,10–12
Between 50% and 75% of patients with osteoarticular TB and
approximately 33–50% of patients with spinal TB have an
associated primary lung focus or have a reported history of
pulmonary TB.3,9,13,14 In one study of spinal TB, MTB was found
elsewhere in the body in approximately 40% of cases, and 50% of
those cases had pulmonary involvement.15 Most reports suggest
that spinal TB results from a primary focus outside of the spine, and
spread is postulated to be via hematogenous or lymphatic
dissemination.2,7,16* Corresponding author. Tel.: +1 650 852 3408; fax: +1 650 858 3978.
E-mail address: pschirme@stanford.edu (P. Schirmer).
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doi:10.1016/j.ijid.2009.11.009While it is common practice to obtain a chest X-ray (CXR) when
a patient is diagnosed with extrapulmonary TB, sputum examina-
tion is typically reserved for thosewith respiratory symptoms and/
or abnormal chest imaging.17 Although TB treatment may not
differ if the sputum is positive for TB, the contact investigation and
isolation proceduresmay vary signiﬁcantly.17–21We present a case
of a patient diagnosed with spinal TB in whom sputum cultures
grewMTB despite a normal CXR. We also review the literature and
discuss the infection control implications and management.
2. Case report
A 62-year-old man was seen in November 2007 reporting a
two-month history of lower back pain, which he attributed to
lifting a heavy object. He was prescribed physical therapy. In
February 2008, he reported having persistent back pain and night
sweats for four months; and because he refused further workup,
physical therapy alone was continued. He was seen several times
in the mental health clinic over the following months where he
continued to report night sweats, which were attributed to post-
traumatic stress disorder. In July, he sawhis primary care physician
and reported approximately one month of chills, left-sided mid-
abdominal pain associated with movement, a bloody bowel
movement, and a 9 kg weight loss over eight months. A history
of a positive tuberculin skin test (TST) was noted, although it was
unknownwhether he had received treatment for latent TB. An HIV
ELISA test was negative. CXR ﬁndings were unremarkable exceptnal Society for Infectious Diseases.
Figure 1. Chest X-ray from August 30, 2008.
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tomography (CT) scan was ordered, but the patient postponed the
study until after his vacation. In August, the patient was seen in the
emergency room for his abdominal pain. An abdominal and pelvic
CT scan revealed a mass extending from T10 to L2, a destructive
process involving the T9, L3, L4 vertebral bodies causing severe
cord compression, and a large rim-enhancing ﬂuid collection in the
right psoas muscle.
The patient was admitted with presumptive Pott’s disease.
Notably, he did not complain of respiratory symptoms. An
admission CXR demonstrated a stable circumscribed opacity in
the right paratracheal region; differential diagnosis included a
prominent right costovertebral junction at the T4 level, an
osteophyte, a mediastinal lymph node, or a soft tissue prominence
(Figure 1). He was placed in respiratory isolation because of this
abnormal CXR ﬁnding in the setting of presumptive Pott’s disease.
Three induced sputums for mycobacterial smear and culture were
obtained over consecutive days. All acid-fast bacilli (AFB) smears
were negative, and airborne isolation was discontinued. A repeat
TST was negative. After a magnetic resonance imaging (MRI) scan
conﬁrmed the CT scan ﬁndings, he underwent abscess drainage
and bone biopsy, performed at the local academic medical center.
Samples from abscess drainage and bone biopsy were AFB smear-
negative, but one week later grew pan-sensitive MTB. Bone
histology demonstrated necrotizing granulomas, consistent with
Pott’s disease. The day after biopsy, empiric four-drug TB therapy
(isoniazid 300 mg daily, ethambutol 20 mg/kg daily, pyrazinamide
25 mg/kg daily, and rifampin 600 mg daily, with pyridoxine 25 mg
daily) was begun.
Three days after starting TB therapy, he developed urinary
retention. A repeat MRI scan demonstrated no interval change.
However, because of changed neurologic exam ﬁndings, emergent
thoracolumbar decompression was performed. Spinal fusion and
further debridement of necrotic bone was performed four days
later. A follow-up CXR demonstrated that the previously noted
right upper lung abnormality was consistent with anterior rib
markings and an osteophyte. Once MTB drug susceptibilities from
the psoas abscess culture were known (one month after starting
treatment), ethambutol was discontinued. Two weeks later,
admission sputum cultures grew pan-sensitive MTB. He was notin respiratory isolation at this time, since he had been on four-drug
TB therapy for over one month and because his initial sputum AFB
smears were negative. As he was nearing discharge after
approximately three months of TB therapy, the local county TB
control ofﬁcer requested three additional mycobacterial sputum
smears and cultures. Two of three sputum samples revealed rare
AFB on smear. A repeat CXR and chest CT scan were not suggestive
of active pulmonary disease. Although he had received directly-
observed therapy, the possibility of drug-resistant MTB was
entertained. He was again placed in airborne isolation until three
additional sputum AFB smears returned negative. All six myco-
bacterial sputum cultures were negative; therefore, it was thought
that the AFB smear-positive samples likely represented dead
organisms. Because he was symptomatically improved, his TB
regimen was not changed. Pyrazinamide was continued for four
months until an MRI scan demonstrated improvement. Currently,
he is clinically improved on isoniazid, rifampin, and pyridoxine.
Although infection control staff had followed the case since
admission, an exposure investigation was initiated when the AFB
smears returnedpositive. Itwasdetermined that the staffworeN-95
respirators during his abscess drainage and bone biopsy (performed
at another institution). Therewas approximately oneweekwhen he
was not in respiratory isolation prior to starting anti-TB treatment
and before the MTB-positive culture results returned. A total of 69
employees and four patients were evaluated at our institution for
possible TB exposure. One patient had a negative Quantiferon test
result (performed because he was unable to return for follow-up
reading). All others had negative symptom review, TST, and CXR
with the exception of one patient, who demonstrated a new TST
conversion, had a normal CXR and whose mycobacterial sputum
culture grew Mycobacterium avium complex.
3. Discussion
Although TB has declined in the USA due to effective public
health surveillance and infection control practices, the public
health ramiﬁcations of undiagnosed pulmonary TB are substan-
tial.1 Our patient presents an interesting question about the
prevalence of spinal TB and concomitant active pulmonary TB. The
prevalence of both spinal and pulmonary TB (both active and
inactive) occurs at a surprisingly high rate (Tables 1 and 2). A total
of 29 individual cases of concomitant pulmonary and spinal TB
have been presented in the literature (Table 1); unfortunately, the
quality of information presented in case reports and case series
varies greatly, with many lacking critical information such as
mycobacterial sputum smear and culture results. Retrospective
studies describing over 3000 patients with spinal TB have noted
that 2–80% of these cases also have evidence of pulmonary TB
(either active or inactive), indicating that further consideration of
this clinical dogma should be entertained (Table 2). However, other
studies suggest a low prevalence of concomitant extrapulmonary
and pulmonary TB. One prospective study from Malawi reported
that 1.7% of patientswith extrapulmonary TB (>3% in patientswith
miliary disease, lymphadenitis or meningitis) had AFB smear-
positive sputum.22 Although no cases of AFB smear-positive
sputum were identiﬁed in the skeletal TB patients, only 42%
submitted sputum samples.22 Unfortunately, information in many
of these studies is incomplete and often does not differentiate
active from inactive disease or provide information about culture
positivity and radiographic ﬁndings.
While physicians often use the presence of respiratory
symptoms or abnormal radiographic ﬁndings in detecting those
at risk for having pulmonary TB, this can bemisleading. Our patient
had no pulmonary symptoms and had a normal chest radiograph,
despite having positive sputum cultures for MTB. Culture-positive
pulmonary TB has been found in patients with extrapulmonary TB
Table 1
Individual reported cases of pulmonary tuberculosis and spinal tuberculosis in the literature
Age/sex AFB sputum
smear and
culture
CXR/CT scan Pathology Tissue for AFBa Therapy Comments/outcome Ref.
Smear Culture/PCR Medical Surgical/site of spinal
disease
23F NR Miliary TB NR Positive Negative INH, EMB, RIF (5mo);
INH, EMB (19 mo)
Anterior spinal fusion
and drainage of
abscess (T6)
Died of unrelated
cause (heroin
overdose)
10
47F NR Healed TB Caseation necrosis Positive Negative INH, EMB, RIF, CY
(6 mo); INH, EMB
(19 mo)
Debridement and
drainage (T12–L1)
Minimal residual
weakness
10
32M NR Healed TB Caseation necrosis,
granulomas
Negative Negative INH, EMB, RIF (4mo);
INH, EMB (18 mo)
Debridement and
anterior spinal fusion,
bone graft (C6–7)
Cured 10
62F NR Miliary TB Granulomas Negative MTB INH, EMB, SM (2mo);
INH, EMB (36 mo)
Anterior spinal fusion
(T7–8)
Marked residual
weakness
(wheelchair bound)
10
42F NR Healed TB Caseation necrosis,
granuloma
Negative MTB INH, EMB, RIF or SM
(11 mo); INH, EMB
(20 mo)
Anterior spinal fusion,
bone graft,
debridement
(T12–L1)
Cured 10
53F NR Healed TB ND ND ND INH, RIF (24 mo) None Cured 10
26M Refused
bronchoscopy and
unable to provide
sputum
Reticulo-nodular
inﬁltration in RUL with
right hilar enlarged
Epithelioid
granulomata with
Langhans giant cells
and
lymphohistiocytic
aggregates
NR NR 4-drug therapy – not
further speciﬁed
VATS; multiple
thoracic and vertebral
involved
Improvement in
bone lesions
2
19M NR Heterogeneous density
increase in left apex;
many nodules with
smooth edges and a
cavitary lesion on CT
scan
Skin: micro-
granuloma, many
Langhans-type giant
cell formation and
dense mononuclear
inﬂammatory cells
Skin lesion:
negative
Skin lesion culture:
negative; PCR:
positive
RIF, INH, SM, EMB (18
mo)
NR; T4–T5 disease Also with cutaneous
lesions. Improved
with healing of skin
lesions by 5th week
59
79M Smear: positive;
culture: positive
Bilateral pseudo-
tumoral inﬁltration
with cavitation in the
RUL; multiple calciﬁed
hilar lymph nodes
NR NR NR NR NR; T9 disease NR 60
66F NR Miliary nodules
bilaterally on CT scan
Intramedullary
lesion: ﬁbrous, diffuse
chronic inﬂammatory
cell inﬁltration with
granulation tissue and
focal abscess
formation
NR Culture: NR; PCR:
positive
RIF, INH, PZA, EMB Laminectomy of
L1–L2 and subtotal
laminectomy of
T10–T11,
myelotomies followed
at T10 and T11
Intramedullary
tuberculomas: spine
and brain with
involvement of L1–2
bone marrow and
end plates. Improved
movement and
decreased size of
tuberculomas
61
25M NR Left pleural effusion;
repeat CXR with right
pleural effusion
Pleural tissue:
thickened pleural
tissue, inﬁltration of
lymphocytes; right
psoas abscess caseous
necrosis with
Langhans giant cells
and epithelioid cells
NR Right psoas abscess:
MTB
INH, RIF, SM Debridement of
T11–12; anterior
spinal fusion, bone
graft
Improved 11
P
.
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Table 1 (Continued )
Age/sex AFB sputum
smear and
culture
CXR/CT scan Pathology Tissue for AFBa Therapy Comments/outcome Ref.
Smear Culture/PCR Medical Surgical/site of spinal
disease
25M Bronchoscopy and
sputum AFB:
negative
Right hilar enlarged,
perihilar inﬁltration
and lytic expansile
lesion of the left 8th
rib; CT: multiple
mediastinal and right
hilar LAD and RUL
consolidation and
vertebral and rib lytic
lesions
Lung and mediastinal
lymph nodes: small
necrotizing
granulomas with
multinucleated giant
cells
Lung and lymph
node tissue:
positive
Lung and lymph
node tissue: MTB
INH, RIF, PZA, EMB VATS; L2–L3 disease Improved 9
20M Smear: positive Apical lesion in RUL ND ND ND INH, EMB No surgical
intervention of
T11–12 disease
Improved 15
24M Culture: MTB LUL inﬁltrate NR NR MTB INH, RIF, PZA, EMB
(2 mo); INH, RIF
(10 mo)
NR; T7–T9 lesion HIV-pos; improved 62
59M Culture: MTB RUL cavity NR NR MTB INH, RIF, PZA, EMB
(2 mo); INH, RIF
(10 mo)
NR; L4 lesion HIV-pos; improved 62
18F Culture: MTB NR Lung tissue: caseating
granulomas; spinal
tissue: caseating
granuloma
NR Spinal tissue: MTB NR Laminectomy; C6,
L1–L2 disease
Patient died 56
21M Negative Negative Lung tissue:
granulomatous
cavitation with
Candida and
Aspergillus seen in
tissue
Spinal: positive Spinal: negative NR NR; T2–T3 disease Patient died 56
26M Negative Mediastinal fusiform
shadow and left
axillary pleural
thickening
Patient refused biopsy ND ND INH, RIF, PZA, EMB
(2 mo); INH, RIF, PZA
(7 mo)
Patient refused;
T7–T8 and L4–L5
disease
Improved 63
25M NR Retrocardiac
mediastinal shadow
NR Retro-pharyngeal
abscess: positive
Retro-pharyngeal abscess
culture: MTB; retro-
pharyngeal abscess
PCR: positive
INH, RIF, PZA, EMB
(2 mo); INH, RIF
(7 mo)
Abscess aspirations.
C2–C3, T8–T9 disease
Improved 63
37M Negative Left apical thickening
of the pleura
Left psoas abscess:
negative
Left psoas abscess: MTB INH, RIF, PZA, EMB
(5 mo); INH, RIF
(7 mo)
Psoas abscess
aspiration; L2–L3
disease
Improved 63
24M Gastric aspirate:
positive
Left pleural effusion
and retro-cardiac mass
NR Spinal: positive Spinal: MTB INH, SM, para-
aminosalicylate
NR; T8–T10 disease Unknown 64
26M Negative 2cm opacity in LUL NR Abscess: positive Abscess: MTB INH, SM, para-
aminosalicylate
NR; lumbar disease Unknown 64
73F Negative;
bronchoscopy
culture: positive
CT: pulmonary
inﬁltrates and ﬁbrosis
of the right lung
Spinal: caseating
granulomas with
multinucleated cells
Spinal: positive NR INH, PZA, RIF (12 mo) NR; mid-thoracic
disease
Improved 65
51M NR CT: tiny nodules
consistent with
miliary disease
Spinal: necrotizing
granulomatous
inﬂammation;
extramedullary mass:
granulomatous
inﬂammation
Spinal: positive;
extra-medullary
lesion: negative
Spinal: culture MTB;
PCR positive
INH, ETH, RIF, SM
(2 mo); INH, RIF
(2mo); INH, ETH, RIF,
SM (restarted for
unknown duration)
T12–L1 laminectomy. Returned due to
worse symptoms and
found to have
extramedullary
mass, subsequently
improved
66
P
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recent study found a signiﬁcant difference in HIV-negative versus
HIV-positive patients with normal CXR ﬁndings in the setting of
active pulmonary TB (5% vs. 22%).26 HIV-infected patients with
normal or atypical CXR ﬁndings in culture-positive pulmonary TB
were similar to those reported in other studies (2–32%).27–42 In one
study of patients (HIV-positive and -negative) with normal CXR
ﬁndings, 48 of 53 had sputumAFB smears performed, ofwhich 21 of
48 were smear-positive.26 Patients with normal CXR ﬁndings were
also signiﬁcantly less likely to report respiratory symptoms on
presentation (32% vs. 13%).26 Published series prior to the HIV
epidemic, or studies not indicatingHIV status, have reported a range
of 1–32% of patients with normal CXR ﬁndings who were found to
have MTB culture-positive sputum.23,25,32–34,41,43–49 HIV-infected
patients with pulmonary TB also have an increased probability of
presenting with AFB smear-negative sputum and normal CXR
ﬁndings compared to non-HIV-infected individuals.28,50 This likely
contributes to delayed TB diagnosis and treatment in HIV-infected
patients.28,50 In summary, little quality data has been published
about the correlation between extrapulmonary TB, culture-positive
pulmonary TB and normal CXR ﬁndings.
Importantly, respiratory transmission of TB has been docu-
mented in patients with AFB smear-negative sputum.17,51–55 Two
studies suggest that approximately 17% of transmission occurred
from persons with sputum smear-negative TB.51,52 One study
found that those with extrapulmonary TB increased the TB
transmission rate, suggesting that the infectiousness of extra-
pulmonary TB has previously been underestimated.51We found no
evidence of transmission in our case. Although evidence of
transmission (other than direct inoculation) of MTB from extra-
pulmonary sources is lacking in the current literature, in-depth
evaluations of the infectiousness and risk of transmission from
extrapulmonary TB have not been adequately documented in the
literature.
Unfortunately, current guidelines offer no clear guidance on
whether or not all patients with extrapulmonary TB should be
evaluated for concurrent pulmonary involvement nor is there an
appropriate infection control strategy delineated for these
patients. Several sources suggest a conservative approach, such
as obtaining cultures from all body ﬂuids and tissues that are
suspected of being involved with MTB.56 The Centers for Disease
Control and Prevention recommends that ‘‘persons diagnosedwith
extrapulmonary TB disease should be evaluated for the presence of
concurrent pulmonary TB disease’’; however, further description of
the extent of that evaluation is lacking.57 According to Mandell’s
Principles and practice of infectious diseases, a CXR should be
routinely obtained in Pott’s disease since abnormal radiographs
can have important health ramiﬁcations.58
The cost of respiratory isolation and obtaining mycobacterial
sputum cultures on all patients with extrapulmonary TBwould not
be trivial. However, cost could be minimized by appropriately
identifying patients who are at risk of having pulmonary TB. At our
institution, routine isolation and subsequent AFB sputum exami-
nation from extrapulmonary TB cases does not always occur unless
pulmonary symptoms or abnormal CXR ﬁndings are noted. From
our literature review and weighing public health considerations of
TB transmission, we suggest that airborne isolation of patients
with suspected extrapulmonary TB, including spinal TB, is justiﬁed
until CXR and AFB sputum smear results are known and cultures
have been obtained. Even though there is documentation of AFB
smear-negative transmission of pulmonary TB, it is customary to
discontinue isolation once negative AFB sputum smear results are
known.
Advantages of taking an aggressive approach to isolation and
documentation of active pulmonary TB include minimizing
healthcare worker and patient exposure to a potentially infectious
Table 2
Studies noting concomitant pulmonary and spinal tuberculosis
Study location Number of patients
with spinal TB
Number of
patients also
with a form of
pulmonary TB (%)
Based
on CXR
Based on
positive
sputum
cultures
No further
details
on lung
disease
Active vs.
inactive vs.
combined
pulmonary TB
Comments Ref.
England 500 284/500 (57) XX Active Known cases of active
pulmonary TB (sputum-
positive) were excluded
68
England 914 175/914 (19) XX Active 443with additional active TB
focus
69
France 103 16/103 (16) XX Combined 28 extraskeletal TB 70
India 15 1/15 (7) XX Inactive Primarily intramedullary TB;
one of these patients with
Pott’s (not the one with
pulmonary disease); no
sputum AFBs sent
71
India and Iran 48 9/48 (19) XX Combined No deﬁnition of ‘a primary
pulmonary focus’
72
Iran 100 18/100 (18) XX XX Combined All patients got a CXR and
sputum smear and culture
73
Korea 244 116/244 (48) XX Combined 69 (28%) active disease; 47
(20%) inactive
74
Nigeria 34 9/34 (27) XX Active 75
Philippines 88 children 88/88 (100) XX Active All had to have spinal TB
associated with active
pulmonary TB to be
included; 2miliary disease, 3
pleural effusion, 8 had
residue of acute pleuritis
16
Saudi Arabia 39 12/39 (31) XX Combined TB of the nervous system; 8
with bony disease (unclear if
any of these had pulmonary
disease as well); 7 with
abnormal CXR: 4 old TB, 3
miliary TB
76
Tanzania 22 children 2/22 (9) XX XX Active AFB sputums were done and
positive only on the 2 with
positive CXR ﬁndings
77
Turkey 694; 35 with
multifocal disease
16/694 (2) XX Combined Of the 35 with multifocal TB
45% had pulmonary
involvement
8
USA 70 10/70 (14) XX Active 9 active; 1 pleurisy; inner
city patients
78
USA 12 6/12 (50) XX Combined Inner city patients 14
USA 62 (48 with CXR;
56 with cultures)
40/48 (83)
based on CXR;
20/56 (37)
based on AFB
XX XX Combined 5 with miliary; combination
of sputum and gastric
aspirates 37%
56
USA (immigrants
from Asia and
Central America)
19 8/19 (42) XX Combined 3 inactive, 3miliary, 1 diffuse
inﬁltrates, 1 pleural effusion;
15 AFB smear/cultures done
but the source of specimen is
unclear
79
USA 20 10/20 (50) XX Combined 7 with calciﬁed adenopathy
and pleural thickening, 3 had
pulmonary inﬁltrates; 1 with
a positive AFB sputum
(unclear if others were
tested)
80
USA 26 2/26 (8) XX XX Active 1 with a left upper lobe
inﬁltrate and the other with
right upper lobe cavity. HIV-
pos patients. Sputum AFBs
only reported on 2 patients
with abnormal CXR
62
USA 230 skeletal
TB patients (138
with spinal TB)
139/230 (60) XX Combined Patients were chosen from a
sanatorium; 117 (51%)
active; 22 (10%) inactive;
unclear how many of these
had spinal involvement
81
TB, tuberculosis; CXR, chest X-ray; AFB, acid-fast bacilli.
P. Schirmer et al. / International Journal of Infectious Diseases 14 (2010) e659–e666e664patient, as well as providing an additional source for MTB culture
and susceptibility testing . Future investigations and publications
require clear deﬁnitions of a pulmonary primary focus as well as
active versus inactive pulmonary TB to help guide appropriateinfection control practices. Finally, better guidance with respect to
isolation practices and appropriate evaluation of extrapulmonary
TB cases, particularly spinal TB, is needed.
Conﬂict of interest: No conﬂict of interest to declare.
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